253 related articles for article (PubMed ID: 17244360)
1. Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma.
Grizzi F; Franceschini B; Hamrick C; Frezza EE; Cobos E; Chiriva-Internati M
J Transl Med; 2007 Jan; 5():3. PubMed ID: 17244360
[TBL] [Abstract][Full Text] [Related]
2. New perspectives and strategy research biomarkers for hepatocellular carcinoma.
Saffroy R; Pham P; Reffas M; Takka M; Lemoine A; Debuire B
Clin Chem Lab Med; 2007; 45(9):1169-79. PubMed ID: 17635075
[TBL] [Abstract][Full Text] [Related]
3. Markers for hepatocellular carcinoma.
Wu AH; Sell S
Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
[TBL] [Abstract][Full Text] [Related]
4. Contribution of biomarkers and imaging in the management of hepatocellular carcinoma.
Fartoux L; Decaens T
Clin Res Hepatol Gastroenterol; 2011 Jun; 35 Suppl 1():S21-30. PubMed ID: 21742297
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment.
Piñero F; Dirchwolf M; Pessôa MG
Cells; 2020 Jun; 9(6):. PubMed ID: 32492896
[TBL] [Abstract][Full Text] [Related]
6. Tudor domain-containing protein 4 as a potential cancer/testis antigen in liver cancer.
Yoon H; Lee H; Kim HJ; You KT; Park YN; Kim H; Kim H
Tohoku J Exp Med; 2011 May; 224(1):41-6. PubMed ID: 21515969
[TBL] [Abstract][Full Text] [Related]
7. Identification of the cancer/testis antigens AKAP3 and CTp11 by SEREX in hepatocellular carcinoma.
Song MH; Choi KU; Shin DH; Lee CH; Lee SY
Oncol Rep; 2012 Nov; 28(5):1792-8. PubMed ID: 22941507
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
Chiou SH; Lee KT
Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
[TBL] [Abstract][Full Text] [Related]
9. Challenges of Clinical Research on Hepatocellular Carcinoma.
Kudo M; Kitano M; Sakurai T; Nishida N
Dig Dis; 2015 Oct; 33(6):780-90. PubMed ID: 26488399
[TBL] [Abstract][Full Text] [Related]
10. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW
Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609
[TBL] [Abstract][Full Text] [Related]
11. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
[TBL] [Abstract][Full Text] [Related]
12. CD99 expression in hepatocellular carcinoma: an immunohistochemical study in the fibrolamellar and common variant of the tumour.
Vasdev N; Nayak NC
Indian J Pathol Microbiol; 2003 Oct; 46(4):625-9. PubMed ID: 15025359
[TBL] [Abstract][Full Text] [Related]
13. Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis.
Ma YC; Yang JY; Yan LN
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1007-16. PubMed ID: 23478672
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of hepatocellular carcinoma using chicken anti-monoclonal antibody--as tumor marker on the heterophilic hanganutziu-deicher antigen].
Koda T; Shimosakoda T; Nishinaka S; Asaoka H; Nakaba H; Tamura I; Matsuda H
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2771-7. PubMed ID: 7993113
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities.
De Matteis S; Ragusa A; Marisi G; De Domenico S; Casadei Gardini A; Bonafè M; Giudetti AM
Oxid Med Cell Longev; 2018; 2018():7512159. PubMed ID: 30524660
[TBL] [Abstract][Full Text] [Related]
16. Potential of immunotherapy for hepatocellular carcinoma.
Breous E; Thimme R
J Hepatol; 2011 Apr; 54(4):830-4. PubMed ID: 21145836
[TBL] [Abstract][Full Text] [Related]
17. [Promoting thorough action for early screening, diagnosis and treatment of liver cancer].
Fan R; Hou JL
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):817-821. PubMed ID: 31941233
[TBL] [Abstract][Full Text] [Related]
18. Current approaches to the diagnosis and management of hepatocellular carcinoma.
Perry JF; Poustchi H; George J; Farrell GC; McCaughan GW; Strasser SI
Clin Exp Med; 2005 May; 5(1):1-13. PubMed ID: 15928877
[TBL] [Abstract][Full Text] [Related]
19. Biological treatment for liver tumor and new potential biomarkers.
Chiriva-Internati M; Grizzi F; Wachtel MS; Jenkins M; Ferrari R; Cobos E; Frezza EE
Dig Dis Sci; 2008 Mar; 53(3):836-43. PubMed ID: 17712633
[TBL] [Abstract][Full Text] [Related]
20. Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma.
Giannelli G; Marinosci F; Sgarra C; Lupo L; Dentico P; Antonaci S
Int J Cancer; 2005 Sep; 116(4):579-83. PubMed ID: 15825162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
